On Tuesday, May 10, 2011, the FDA hosted a public meeting to gather stakeholder input regarding a proposed generic drug user fee program. A user fee program could provide necessary supplemental funding, in addition to current Congressional appropriations, to facilitate the timely review of human generic drug applications by FDA, and FDA is currently in negotiations with the regulated industry aimed at providing a consensus proposal for congressional consideration.

FDA has reopened the docket at Regulations.gov through which stakeholders can provide comment. The docket number is FDA-2010-N-0381.

To view a summary of the meeting: http://www.fda.gov/downloads/Drugs/NewsEvents/UCM255187.pdf

To view the slide presentation from the meeting: http://www.fda.gov/downloads/Drugs/NewsEvents/UCM255189.pdf

This entry was posted in PET Drugs. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s